Bright Minds Biosciences Inc (DRUG)
R&D Expense Growth
-28.41%
Quarterly · Period ending:
DRUG R&D Expense Growth
Latest reported-28.41%period ending
Latest reported-28.41%period ending
DRUG Quarterly R&D Growth (QoQ) (0.00% → -28.41%)
Latest values, visible window
High-resolution chart · PNG
DRUG r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -28.4093% | |
| 134.3396% | |
| 18.3196% | |
| 77.729% | |
| 5.0241% | |
| 145.1847% | |
| 151.2572% | |
| 173.4108% | |
| -638.8372% | |
| -91.4175% | |
| 12.2979% | |
| 3.867% | |
| -24.858% | |
| -4.2072% | |
| -42.5595% | |
| 23.8789% | |
| -45.1979% | |
| -2.6514% | |
| 74.1378% | |
| -18.464% | |
| 159.17% | |
| 196.1893% | |
| 19.1966% | |
| 1,281.6404% | |
| 258.6472% | |
| -80.9425% | |
| 0% |